about
Metabolic disturbances in diseases with neurological involvementEffects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 miceRelationship between fractional anisotropy of cerebral white matter and metabolite concentrations measured using (1)H magnetic resonance spectroscopy in healthy adults.Proton MRS in mild cognitive impairment.Magnetic resonance spectroscopy in Alzheimer's disease.A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 miceMagnetic resonance spectroscopy in common dementiasHippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.Advances in high-field magnetic resonance spectroscopy in Alzheimer's diseaseAdvances in MRI biomarkers for the diagnosis of Alzheimer's disease.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates.In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatmentMRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathologyShort echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point studyCombining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disorders.Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.Emerging biomarkers in cognition.Rare copy number deletions predict individual variation in human brain metabolite concentrations in individuals with alcohol use disorders.Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented eldersRegion-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using 1H magnetic resonance spectroscopy at 7 T.Neurometabolite concentration and clinical features of chronic alcohol use: a proton magnetic resonance spectroscopy study.High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group Metabolism.Imaging the Alzheimer brain.MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementiaMRI and MRS predictors of mild cognitive impairment in a population-based sample.APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.Moderate relationships between NAA and cognitive ability in healthy adults: implications for cognitive spectroscopyOther dementias.The development of effective biomarkers for Alzheimer's disease: a review.EFNS task force: the use of neuroimaging in the diagnosis of dementia.Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females.A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.On the emerging role of neuroimaging in determining functional and structural brain integrity induced by physical exercise: impact for predictive, preventive, and personalized medicine.Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET.Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
P2860
Q26999015-FB620CF0-54FD-4D04-AD5B-0215777ED34BQ28533783-FC21EF77-0FAE-4741-A685-A0D4B3AB256BQ30573753-81FC4176-D854-4217-BC3C-8C671DA95B9AQ30606675-4847FB93-9646-4B12-A400-A9E831D25F85Q30630699-3FC95832-5D18-4683-9092-3E258CC9599EQ30635401-CB14E12C-7F25-41DB-8E22-4439BA161387Q30660402-DFCEC9FA-C115-443E-95F6-37202BA79F5CQ30758233-0C90C5EA-A99E-49B7-880B-E1B0AFE5AAB8Q30770751-B168D4F5-1947-4205-9E6B-73446E910A8EQ30870223-8AAE23FF-D762-47DC-955C-B6118E855FBAQ30996805-61C31E1C-9A95-4ECA-86A3-08A87C534228Q33425247-F456C962-A3D7-4F85-9CA4-82B402A00687Q33427621-D7CD3161-29F6-430B-AB5B-66CB08CFD1FAQ34125535-9AAE80F0-958B-422C-913B-74DF745C8C3FQ34247831-54FAA9C4-4C2C-4F1B-8FE6-F9CED302A033Q34448709-23F1EBB3-2DD2-4C5C-BE9E-A98F1164C540Q34614543-2174C799-F58B-4C99-9C65-6E4ECC47034AQ35008258-F94350D1-8DF2-4DC6-81F5-EDBFB683AB2AQ35182074-83B914B9-2FE6-42F6-A335-0736143425EFQ35210272-C8CCF193-194E-4AAD-86EE-0AC08C3F764EQ36083501-0CA3FBD4-5D39-40F9-BC40-D2C286E90D9FQ36364569-8D6477F7-6CBA-4FC3-82B5-7CBF7E0BFBFBQ36605449-31003DB3-D2E9-4323-B204-745F9749ACF7Q37060029-38A961B2-1064-4FF3-8077-C57387973E96Q37141502-69480A45-37EB-42A1-8217-7CD67D92DB7BQ37150803-D9A88367-E3C3-4E52-BE92-5FBA75130692Q37163305-D5A6D584-E9CC-4B6A-8F07-AA309DE40A82Q37459037-8F92BCC9-A157-4AA3-87BC-240B9497D667Q37583283-6233CEC0-6243-4B53-9A43-BE0C3CF31BAFQ37921665-D4C76289-E56E-4A54-844B-06C260EA80D0Q38016800-E5918EBD-C8FD-4579-B9CD-16DA0312A4C1Q38035398-BE22297D-B6BE-4215-BFFE-3918F5E4730FQ38084188-759518DC-ADB7-4B89-9438-7A9681004D2FQ38190687-1ED5326C-7DDE-4B0A-BF47-E29F0A1D0F2FQ38461379-401C0F2D-EB94-42DA-9FF7-CD6661BD4B01Q39319443-EB1AFFDA-0388-44A3-8DE8-F2EB65C59278Q40316451-FFAA40E0-7BB1-459B-AD6E-2237500B8438Q42250388-47447501-BA30-4D7A-BF95-FA2B467E5F1AQ44793917-EA9B45B7-8D1B-425D-A839-856DCB5B8EB5Q44937365-45A9D472-F277-418E-98E3-8FEF91AA5393
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
1H magnetic resonance spectroscopy in dementia.
@en
1H magnetic resonance spectroscopy in dementia.
@nl
type
label
1H magnetic resonance spectroscopy in dementia.
@en
1H magnetic resonance spectroscopy in dementia.
@nl
prefLabel
1H magnetic resonance spectroscopy in dementia.
@en
1H magnetic resonance spectroscopy in dementia.
@nl
P2860
P356
P1476
1H magnetic resonance spectroscopy in dementia.
@en
P2860
P304
P356
10.1259/BJR/60346217
P407
P478
80 Spec No 2
P577
2007-12-01T00:00:00Z